logo

US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy

By: theblockbeats.news|2025/08/04 13:02:14

BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.


This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.

The Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOL

You may also like

Share
copy

Gainers

Latest Crypto News

15:45

Bloomberg: FDUSD Issuer First Digital Plans to Go Public on the US Stock Market Through SPAC Merger

15:45

「Buddy」 once again made a deposit to Hyperliquid of approximately 250,000 U to top up his ETH long position.

15:15

Sushi CEO Announces Resignation to Become Advisor, Solidity.io Founder Alex McCurry to Take Over as CEO

15:15

Circle Issues an Additional 1 Billion USDC on the Ethereum Network

15:15

US Crypto Stocks Experience General Decline, MSTR Drops by 6.15%, BMNR Drops by 7.91%

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]